FDA Issues Warning Letters to 15 Companies Selling CBD Products

Cannabidiol (CBD) is an increasingly popular product throughout the country. It’s marketed as a supplement to improve health, cognition, mood, and stress levels. However, the U.S. Food and Drug Administration (FDA) recently issued warning letters to 15 companies that sell CBD products that are in violation of the Federal Food, Drug, and Cosmetic Act. In addition, the FDA also published a revised Consumer Update concerning CBD and its potential safety concerns.

To date, the FDA has approved only one CBD product for sale in the U.S.—a prescription drug that’s designed to treat two rare and severe forms of epilepsy. The Consumer Update indicates that it’s illegal for companies to market CBD by adding it to food products or labeling it as a dietary supplement.

According to the FDA, potential risks associated with CBD include:

  • Liver injury
  • Changes in the metabolism of medications, potentially resulting in serious side effects
  • Increased risk of sedation and drowsiness when used with alcohol or other depressants
  • Changes in alertness
  • Gastrointestinal distress
  • Irritability and agitation
  • Toxicity to the male reproductive system

In addition, the FDA has expressed concerns over the quality and manufacturing standards of products containing CBD, as dosages may be incorrect and impurities may be present.

At Ferrer, Poirot & Wansbrough, our personal injury lawyers are always on the lookout for products that harm innocent people. If you or someone you love suffered an injury, illness, or complication after taking a potentially dangerous medication, supplement, or product, we want to help. Contact us today for a free consultation.